Ga68-PSMA PET/CT
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Ga68-PSMA PET/CT, covering 2024-05-17 to 2024-05-17. Get the full timeline:
Most recent: Clinical Trial Update: Fluciclovine F18 or Ga68-PSMA PET/CT to Enhance Prostate Cancer Outcomes [Phase 2]